News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kenta Biotech Announces Collaboration with Rentschler Biotechnologie GmbH & Co. for Antibody Development Against Hospital-Acquired Infections


1/14/2010 9:38:36 AM

BERNE, Switzerland--(BUSINESS WIRE)--Kenta Biotech today announced an agreement with Rentschler Biotechnologie for the development of a fully human monoclonal antibody against methicillin-resistant Staphylococcus aureus (MRSA).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES